Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KHO, Summerbell CD, Worthington HV, Song F, Hooper L
Published in Cochrane Database of Systematic Reviews
Methodology
Cochrane systematic review of randomized trials of long-chain and plant-based omega-3 fats including alpha-linolenic acid for cardiovascular prevention
Key Findings
Increasing alpha-linolenic acid intake probably makes little or no difference to all-cause mortality or cardiovascular events, with possible small reductions in cardiovascular mortality and arrhythmia
Conclusions
Plant omega-3 supplementation has at most small cardiovascular effects
Limitations
Few dedicated alpha-linolenic acid trials; wide confidence intervals
Supplements Studied
Increasing alpha-linolenic acid intake probably makes little or no difference to all-cause mortality or cardiovascular events, with possible small reductions in cardiovascular mortality and arrhythmia
Increasing alpha-linolenic acid intake probably makes little or no difference to all-cause mortality or cardiovascular events, with possible small reductions in cardiovascular mortality and arrhythmia
Outcomes Measured
Omega-3 supplementation has little or no effect on cardiovascular events.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.